{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:56:36Z","timestamp":1781567796830,"version":"3.54.5"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI001123"],"award-info":[{"award-number":["AI001123"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI001124"],"award-info":[{"award-number":["AI001124"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0159727","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T13:44:00Z","timestamp":1470318240000},"page":"e0159727","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence"],"prefix":"10.1371","volume":"11","author":[{"given":"Jairo M.","family":"Montezuma-Rusca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigit","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"Aids"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e56269","DOI":"10.1371\/journal.pone.0056269","article-title":"Epidemiology of Cryptococcal Meningitis in the US: 1997\u20132009","volume":"8","author":"V Pyrgos","year":"2013","journal-title":"PLoS One"},{"key":"ref3","first-page":"45","article-title":"Prognosis and management of cryptococcal meningitis in patients with human immunodeficiency virus infection","volume":"2012","author":"J BD Rhein","year":"2012","journal-title":"Neurobehavioral HIV Medicine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s40506-014-0026-0","article-title":"Outcomes assessments in clinical trials of cryptococcal meningitis: consideration on use of early fungicidal activity as a potential surrogate endpoint for all-cause mortality","volume":"6","author":"JM Montezuma-Rusca","year":"2014","journal-title":"Current Treatment Options in Infectious Diseases"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"JN Jarvis","year":"2012","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"AE Brouwer","year":"2004","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"JC Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"A Loyse","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"T Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e328354b419","article-title":"A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis","volume":"26","author":"AT Jackson","year":"2012","journal-title":"AIDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/cid\/cit019","article-title":"Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis","volume":"56","author":"GP Bisson","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"JN Day","year":"2013","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis","volume":"374","author":"J Beardsley","year":"2016","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1086\/520141","article-title":"A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS","volume":"29","author":"DL Cohn","year":"1999","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate end points in clinical trials: are we being misled?","volume":"125","author":"TR Fleming","year":"1996","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0962280207082719","article-title":"The Biomarker-Surrogacy Evaluation Schema: a review of the biomarker-surrogate literature and a proposal for a criterion-based, quantitative, multidimensional hierarchical levels of evidence schema for evaluating the status of biomarkers as surrogate endpoints","volume":"17","author":"MN Lassere","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"ref17","unstructured":"Institute of Medicine (2010) Evaluation of biomarkers and surrogate endpoints in chronic disease."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jamainternmed.2015.2829","article-title":"The Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analyses","volume":"175","author":"V Prasad","year":"2015","journal-title":"JAMA Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/088922200308873","article-title":"Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team","volume":"16","author":"S Kim","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/annonc\/mdv507","article-title":"Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer","volume":"27","author":"EL Korn","year":"2016","journal-title":"Ann Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"T Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.0006-341X.2001.01198.x","article-title":"Small-sample adjustments for Wald-type tests using sandwich estimators","volume":"57","author":"MP Fay","year":"2001","journal-title":"Biometrics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/0962280207081864","article-title":"Individual- and trial-level surrogacy in colorectal cancer","volume":"17","author":"M Buyse","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"T Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/sim.5403","article-title":"Biomarkers and surrogate endpoints in clinical trials","volume":"31","author":"TR Fleming","year":"2012","journal-title":"Stat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/516165a","article-title":"Microbiology: Ditch the term pathogen","volume":"516","author":"A Casadevall","year":"2014","journal-title":"Nature"},{"key":"ref29","article-title":"How to stop crypto, a deadly disease so neglected it's missed on the 'neglected' list","author":"P Adams","year":"2016","journal-title":"Newsweek"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)","volume":"61","author":"SR Evans","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1080\/00365540701383147","article-title":"Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: a randomized controlled trial","volume":"39","author":"M Techapornroong","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/516372","article-title":"Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS","volume":"26","author":"H Mayanja-Kizza","year":"1998","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"RJ Hamill","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref34","first-page":"416","article-title":"Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS","volume":"80","author":"V Chotmongkol","year":"1997","journal-title":"J Med Assoc Thai"},{"key":"ref35","first-page":"1677","article-title":"Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients","volume":"89","author":"S. Tansuphaswadikul WN","year":"2006","journal-title":"Journal of the Medical Association of Thailand"},{"key":"ref36","first-page":"170","article-title":"Initial treatment of cryptococcal meningitis in AIDS","volume":"36","author":"V Chotmongkol","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0022-3859.65276","article-title":"Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV\/AIDS patients in India: a multicentric, randomized controlled trial","volume":"56","author":"MP Jadhav","year":"2010","journal-title":"J Postgrad Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis","volume":"48","author":"PG Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1086\/420829","article-title":"Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis","volume":"189","author":"PG Pappas","year":"2004","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"RA Larsen","year":"1990","journal-title":"Ann Intern Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199202000-00007","article-title":"Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis","volume":"6","author":"J de Gans","year":"1992","journal-title":"Aids"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00002030-199712000-00010","article-title":"Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis","volume":"11","author":"AC Leenders","year":"1997","journal-title":"Aids"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group","volume":"337","author":"CM van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc1305981","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"JN Day","year":"2013","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1086\/652652","article-title":"Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa","volume":"50","author":"AT Makadzange","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199201093260202","article-title":"Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group","volume":"326","author":"MS Saag","year":"1992","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinids\/22.2.315","article-title":"Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS","volume":"22","author":"PK Sharkey","year":"1996","journal-title":"Clin Infect Dis"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJM197907193010303","article-title":"A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis","volume":"301","author":"JE Bennett","year":"1979","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJM198708063170602","article-title":"Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks","volume":"317","author":"WE Dismukes","year":"1987","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0159727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T03:57:04Z","timestamp":1540267024000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0159727"}},"subtitle":[],"editor":[{"given":"Eliseo A","family":"Eugenin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0159727","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}